[1] 赵志刚,王爱国. 当代药品商品名与别名辞典[M].2006. 北京:化学工业出版社. 451. [2] 刘茂顺,范建荣,訾梅. 特非那丁的药物流行病学概况及应用价值评价[J]. 药物流行病学杂志, 1999,8(3):129-132. [3] Woosley RL, Chen Y, Freiman Jea. Mechanism of the cardiotoxic actions of terfenadine[J]. JAMA, 1993,256(12):1532-1536. [4] Terfenadine to be withdrawn in the US[J]. Reactions Weekly, 1998,683(10 Jan):2. [5] Terfenadine: prescription only status recommended in UK[J]. Reactions Weekly, 1997,650(May 10):2 [6] Terfenadine and astemizole will be reclassified to prescription-only in Canada[J]. Reaction weekly, 1997,682(20):2. [7] 刘萍. 大剂量特非那定已被停用[J].药学进展, 1999,23(3):188. [8] Davies AJ, Harindra V, McEwan A et al. Cardiotoxic effect with convulsions in terfenadine overdose[J]. BMJ, 1989,298(6669):325. [9] Glassman AH, Thomas Bigger J. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death[J]. American journal of psychiatry, 2001,158(11):1774-1782. [10] Rajput SK, Singh JN, Sharma SS. Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs[J]. Pharmacological Reports, 2010,62(4):683-688. [11] 吕吉元等. 特非那丁对心律失常防治作用的研究[J].中华心律失常学杂志, 2009,13(4):279-282. [12] Aslanian R, Piwinski JJ, Zhu X. Structural determinants for histamine H1 affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs[J]. Bioorganic & Medicinal Chemistry Letters, 2009,19(17):5043-5047. [13] 国家食品药品监督管理局.什么是药物相互作用[EB/OL].[2012-01-05] http://former08.sfda.gov.cn/WS01/CL0112/23734.html. [14] 国家食品药品监督管理局.什么是药物相互作用[EB/OL]. [2012-01-05] http://www.sfda.gov.cn/WS01/CL0445/28914.html. [15] 国家食品药品监督管理局信息中心.数据查询[EB/OL]. http://app1.sfda.gov.cn/datasearch/face3/base.jsp. [16] 孙宇,刁树玲,王文英. 特非那定致尖端扭转性室性心动过速一例[J]. 中华心律失常学杂志, 2001,5(1):43. [17] 张建军,王洋. 特非那定致严重心脏毒性1例[J].中国医学创新, 2010,7(21):192. [18] 万雨明,李明. 特非那定致窦性心动过缓伴心律不齐1 例[J]. 中国临床药学杂志, 2000,9(4):248. [19] 卫应. 警惕特非那定的心脏毒性[J]. 药物不良反应杂志, 2001,3(1):36. [20] 蒋亚生,时晓鸿. 特非那定的临床不良反应分析[J]. 中国药业, 2000,9(11):56. |